Page 94 | Certara

Press Coverage

LABO: Data utilisation and data infrastructure in drug development: Data, Data, Data

Published: April 12, 2023 This is the German article written by Dr. Fabian Rauscher, Scientific…

CertaraApril 12, 2023

Video

Milestone Achieved: Simcyp 100

CertaraApril 11, 2023

Brochure

Drug Discovery & Development with Deep Learning Advanced Analytics

Solutions to Meet All Needs: From Small Biotech to Large Global Pharma

CertaraApril 6, 2023

Blog

Considerations for Pricing & Formulary Access for DRG-Funded Hospital Drugs

In the United States, treatments or medical services that require the patient be admitted into…

CertaraApril 6, 2023

Case Study

Using Real World Evidence to Inform Treatment Guidelines

Real-World Evidence (RWE) has become increasingly valuable in informing the development of treatment guidelines for…

CertaraApril 5, 2023

Case Study

Using Real Word Evidence to Enhance Drug Development

Real-world evidence (RWE) has emerged as an increasingly important tool in the drug development process,1…

CertaraApril 5, 2023

Press Coverage

Using Quantitative Systems Pharmacology Modelling to Accelerate Drug Development

Model informed drug development (in silico modelling) continues to be a game changer in accelerating…

CertaraMarch 29, 2023

Press Coverage

Model-Informed Drug Development (MIDD) – EMA’s Advancement

Modelling and simulation (M&S) plays a crucial role in drug development. It allows information from…

CertaraMarch 29, 2023

Blog

Tips & Tricks for Optimizing Your Pharmacokinetic Modeling & Simulation

Learn how to streamline your PK/PD workflows with expert tips.

CertaraMarch 23, 2023

White Paper

Advancing Biopharmaceutics & Drug Formulation Using In Silico Modeling

Model-Informed Formulation Development (MIFD) Increases Speed and Certainty for New and Generic Drugs

CertaraMarch 22, 2023

LABO: Data utilisation and data infrastructure in drug development: Data, Data, Data

Milestone Achieved: Simcyp 100

Drug Discovery & Development with Deep Learning Advanced Analytics

Considerations for Pricing & Formulary Access for DRG-Funded Hospital Drugs

Using Real World Evidence to Inform Treatment Guidelines

Using Real Word Evidence to Enhance Drug Development

Using Quantitative Systems Pharmacology Modelling to Accelerate Drug Development

Model-Informed Drug Development (MIDD) – EMA’s Advancement

Tips & Tricks for Optimizing Your Pharmacokinetic Modeling & Simulation

Advancing Biopharmaceutics & Drug Formulation Using In Silico Modeling

Newsletter sign up

Quick links

Solutions

Contact